Methods

Subjects
This study was approved by the Institutional Review Board of Severance Hospital at the Yonsei University Health System and was registered at ClinicalTrials.gov (registration number: NCT01604915). This randomized, double-blind study was conducted at a single tertiary medical centre (Severance Hospital) in Seoul, Republic of Korea, between May 2012 and February 2013. After obtaining written informed consent from parents, we enrolled a total of 80 children aged 6 months to 5 yr of ASA physical status I or II, undergoing day-case, unilateral orchiopexy. Exclusion criteria included a history of developmental delay or mental retardation, type I diabetes, known or suspected coagulopathy, known allergy to any local anaesthetic or steroid, known congenital anomaly of the spine, or signs of spinal anomaly or infection at the sacral region.
Anaesthesia
No premedication was administered. Anaesthesia was induced with 2-3 mg kg 21 of propofol or 8% of sevoflurane in 100%
oxygen. Standard monitors including electrocardiography, non-invasive arterial pressure, pulse oximetry, carbon dioxide, and gas analyser were applied during induction and maintenance of anaesthesia. The airway was established using a laryngeal mask airway (LMA). Anaesthesia was maintained with sevoflurane, and depth of anaesthesia was adjusted accordingly with a goal of 80-120% baseline arterial pressure and 4.7 -6 kPa end-tidal carbon dioxide (E ′ CO 2
). Spontaneous breathing was maintained during surgery. After completion of surgery, the LMA was removed, and the child was sent to a post-anaesthetic care unit (PACU) so long as there was no compromise in airway or haemodynamic instability perioperatively.
Intervention
Enrolled children were randomly assigned to either Group C (control) or Group D (dexamethasone adjunct) according to a computer-generated randomization table. For caudal blocks, Group C received 1.5 ml kg 21 of 0.15% ropivacaine (maximum volume 20 ml); Group D received 1.5 ml kg 21 of 0.15% ropivacaine in which dexamethasone 0.1 mg kg 21 was diluted (maximum volume 20 ml). Yuhan dexamethasone sodium phosphate injectate w (5 mg ml 21 , Yuhan Co., Seoul, Republic of Korea) was used in this study; 1 ml of Yuhan dexamethasone sodium phosphate injectate w contains methylparaben 0.85 mg and propylparaben 0.15 mg as preservatives. An investigator who did not participate in the care of the enrolled children prepared all study medications according to group assignment. Another investigator (E.M.K., clinical professor), who was blinded to group assignments, performed caudal blocks in all patients. After induction of anaesthesia, children were placed in a left lateral decubitus position. After the sacral cornua and hiatus were visualized by ultrasonography, the location of needle entry site was marked over the sacro-coccygeal ligament midway from the cornua. The optimal angle to approach the sacral epidural space was measured, and then a 5 cm short bevelled 22 G block needle was inserted into the sacral epidural space. An aspiration test was conducted to exclude intravascular placement. As the medication was being administered, turbulence in the sacral caudal space on ultrasound imaging of the transverse plane was checked to confirm the spread of injected medications into the epidural space. Fifteen minutes after performing the caudal block, surgery was initiated. The caudal block was considered to have failed if the patient moved his or her limbs, had an increase in heart rate, had an increase in mean arterial pressure, or both of more than 15% compared with baseline during the surgery. In such instances, the patient was to be withdrawn from the study and treated with 1 -2 mg kg 21 of fentanyl.
Assessments
Another investigator who was blinded to group allocation provided postoperative care and assessments. Postoperative pain during the hospital stay was assessed using the Children's Hospital of Eastern Ontario Pain Scale (CHEOPS, 0-10) 12 and the Faces Legs Activity Cry Consolability tool (FLACC, 0-10) 13 at 30 min and 1, 2, and 3 h after operation. A child with a score of more than 4 on both CHEOPS and FLACC received 0.5 mg kg 21 of fentanyl i.v. for rescue analgesia. Motor function was assessed using the following scale: 0, no motor block; 1, able to move legs; 2, unable to move legs. The presence of other adverse events including bradycardia, hypotension, respiratory depression, retching, vomiting, or urinary catheterization was evaluated. Hypotension and respiratory depression were defined as ,80% of baseline arterial pressure and ,95% of pulse oxygen saturation, respectively. The decision to place a urinary catheter for urinary retention and the evaluation of micturition were made by an urologist. Children were discharged from the hospital when they met the following discharge criteria: conscious, haemodynamically stable, tolerating oral intake, voiding, walking in an appropriate manner for age, with the absence of retching, vomiting, and other side-effects.
14 After discharge, pain was assessed by parents who were also blinded to group assignment. The investigator, who was blinded to group allocations and provided postoperative care, educated the parents on how to rate pain according to verbal and non-verbal expressions of pain and behavioural change after surgery on a numeric rating scale (NRS) from 0 to 10, with 0 representing 'no pain' and 10 representing 'the worst pain possible'. 15 The parents were instructed to assess pain at least once an hour. Oral ibuprofen was prescribed for analgesia after discharge. Children received 5 mg kg 21 of ibuprofen for pain scores of 4 or greater on NRS. Information regarding pain levels and the use of analgesia after discharge was obtained via telephone calls to parents at 6, 24, and 48 h after surgery. The investigator inquired about present NRS, maximal NRS since the previous inquiry, and time and number of ibuprofen administration by parents. For NRS scores of zero at all time-points, the investigator asked the additional question of whether the child had been pain free for 48 h since the surgery. One week after operation, urologists checked the surgical wound to rule out other problems such as infection.
Statistical analysis
Based on previous data 16 from our centre, a target sample size was calculated. Among patients who received caudal block with 1.5 ml kg 21 of 0.15% ropivacaine alone, 50% needed oral analgesics after discharge. To demonstrate a 35% difference in this study, at least 36 subjects in each group were required (a¼0.05, b¼0.1). Assuming an estimated 10% droprate, a total of 80 subjects were enrolled. Comparisons between the groups were performed with Student's t-test, the Mann -Whitney rank-sum test, the x 2 test, and Fisher's exact test when appropriate. A P-value of ,0.05 was considered significant. All statistical analyses were performed using IBM SPSS statistics 20 (SPSS Inc., Chicago, IL, USA).
Results
A total of 80 subjects were enrolled in the study and five were excluded in total. Three subjects (two in Group C and one in Group D) were excluded because attending anaesthesiologists administered propofol to treat agitation that could not be controlled by fentanyl administration. Another child in Group C received medications including a non-steroidal antiinflammatory drug during the study period because of an upper respiratory infection after discharge. Lastly, we could not contact the parents of another child in Group D. Therefore, these five subjects were all excluded from the study (Fig. 1 ). The two groups did not differ in terms of patient characteristic data and surgical profiles (Table 1) . Caudal block was deemed successful in all subjects. Until discharge from hospital, FLACC scores were comparable between the groups. CHEOPS scores at 1, 2, and 3 h after surgery were higher in Group C than in Group D with statistical significance (Table 2) . However, the differences in CHEOPS scores between the groups were ,1 point. There was no difference in the number of subjects who had rescue analgesia with fentanyl [seven subjects in Group C (18.9%) and four in Group D (10.5%), P¼0.304].
There were no cases of motor block after surgery. Vomiting was observed in only one subject from Group C in the PACU. Figure 2 presents pain scores determined by parents during the 48 h postoperative period. Group D had significantly lower NRS scores than Group C, with the exception of scores at the 48 h postoperative mark. The number of subjects who were pain free during the 48 h postoperative period was significantly greater in Group D (19 of 38, 50%) than in Group C (four of 37, 10.8%, P,0.001). Consumption of oral analgesics during the postoperative 48 h is shown in Figure 3 and Table 3 . According to a Kaplan-Meier curve depicting time to first oral analgesic administration after surgery, analgesic duration of Group D was significantly longer than that of Group C (P¼0.014). The number of subjects who had oral analgesic during the postoperative 48 h was significantly less in Group D (11 of 38, 28.9%) than in Group C (20 of 37, 54.1%, P¼0.027) and so was the number of oral analgesic administration (P¼0.013). Table 4 demonstrates adverse events after hospital discharge with no significant differences between the two groups. Postoperative wound dehiscence was seen in one case from each group, and the two patients recovered with conservative care within the 3 month follow-up period. Two subjects experienced vomiting in Group C, with no cases of vomiting in Group D after discharge.
Discussion
This study demonstrates the analgesic efficacy of caudal dexamethasone in children undergoing day-case orchiopexy. The addition of dexamethasone can increase the analgesic duration of caudal block with ropivacaine. Furthermore, pain severity and analgesic consumption decreased by the postoperative 48 h. Among subjects who received dexamethasone in their caudal block, half experienced no pain and 71% required no oral analgesics during the 48 h postoperative period-a significantly higher proportion compared with subjects who did not receive dexamethasone.
After day-case orchiopexy, children without caudal block reported clinically significant pain, and about 90% of them needed analgesia. Furthermore, about 70% required more than one type of analgesic.
1 Caudal block using ropivacaine alone can reduce pain and analgesic consumption after orchiopexy in children. About 46% of subjects in Group C with ropivacaine alone needed no analgesic after discharge, which is consistent with the finding of a previous study for paediatric orchiopexy, which demonstrated that caudal block with 1.5 ml kg 21 of 0.15% ropivacaine provided prolonged analgesia and reduced analgesic consumption after discharge, compared with that with 1.0 ml kg 21 of 0.225% ropivacaine. 16 Based on this study, 16 we selected the former concentration and dose of ropivacaine for caudal analgesia. Because the analgesic duration of ropivacaine is 4-6 h 17 and caudal block with ropivacaine could provide sufficient analgesia in children undergoing orchiopexy for the immediate postoperative period, additional rescue analgesia might not be required. 16 Hence, postoperative pain during hospital stay was assessed with two types of pain scales for infants and children to avoid inappropriate administration of rescue fentanyl. Differences in pain scores were not clinically significant between the groups for postoperative 3 h, and this was probably due to the analgesic duration of ropivacaine, thus adding dexamethasone would not make any clinically significant difference in pain scores and rescue fentanyl administration for several hours after operation. Clinically relevant differences in pain scores and analgesic consumption between the groups occurred after 6 h after surgery, and this is consistent with the end of analgesic duration of ropivacaine. Adding dexamethasone can significantly increase the analgesic duration of caudal block with ropivacaine and reduce pain scores and analgesic consumption for postoperative 48 h. Unlike other adjuvants to caudal block investigated in previous studies, 3 -6 no adverse events were observed with dexamethasone during postoperative recovery. Dexamethasone is commonly used in the perioperative period to reduce postoperative nausea and vomiting. 18 Additionally, it has been reported to have analgesic effects. 7 -9 Recently, several studies have demonstrated that epidural administration of dexamethasone prolonged analgesic effects and reduced analgesic requirements in adults. 10 11 Also, the use of dexamethasone as an adjuvant to local anaesthetics during brachial plexus block effectively improved the quality of analgesia without side-effects. 19 20 The precise mechanism of analgesic effect of epidural or perineural dexamethasone administration is not clearly understood. Dexamethasone might have a local anaesthetic effect on nerve by direct membrane action. 21 Therefore, dexamethasone might potentiate the effect of ropivacaine and prolong the duration of analgesia. Another possible mechanism involves the effect of dexamethasone on the spinal cord. The transcription factor nuclear factor-k B (NF-kB) is expressed throughout the nervous system and plays an important role in the development of pathological pain. 22 Dexamethasone could regulate NF-kB; 23 more specifically, epidural injection of corticosteroid has been reported to inhibit development of hyperalgesia with associated reduction in NF-kB levels. 24 These findings suggest that dexamethasone might prevent central sensitization after surgery and strengthen the preventive analgesia of caudal block. Our finding that a higher proportion of children in Group D were without pain during the postoperative 48 h period compared with Group C could be due to the prevention of hyperalgesia at the spinal cord level. Epidural corticosteroids have a long history of safe use in the treatment of low back and radicular pain. 25 To date, no significant side-effects have been reported for epidural dexamethasone. 26 Although there is no direct evidence regarding the safety of dexamethasone administered through an epidural route in children or young animals, as far as we know, an in vitro experiment demonstrated that direct exposure to neural cell cultures dexamethasone for 12 h was not neurotoxic. 27 In a study of the neurotoxicity of adjuvants used in regional anaesthesia, dexamethasone attenuated bupivacaine-induced neuronal injury 28 and did not significantly increase ropivacaine-induced neuronal death. 29 The safety of methylparaben and propylparaben, the preservatives included in dexamethasone injectate, has been proven even in intrathecal injection of human and animal models. 30 31 However, high-dose dexamethasone is associated with complications such as hyperglycaemia, 32 wound infection, 33 postoperative bleeding, 34 and transient adrenal suppression.
35 (14) 34 (11) Duration of anaesthesia (min)
64 (13) 60 (10) Fluid administered (ml) 74 (21) 73 (17) Mean arterial pressure (mm Hg) T1 67 (13) (14) 130 (16) Sevoflurane concentration (end-tidal vol%) Analgesic efficacy of caudal dexamethasone in children Therefore, there is a body of opinion that prefers lower dose epidural steroids due to concern for corticosteroid-related sideeffects. 36 In our study with low dose of dexamethasone, there were no differences in the incidence of adverse effects including postoperative fever, wound infection, or dehiscence. Our study has several limitations. First, we cannot completely exclude the possibility that caudal dexamethasone exerts analgesic effects through systemic absorption because i.v. dexamethasone has been reported to have analgesic effects. 7 -9 The dose of caudal dexamethasone (0.1 mg kg 21 )
in our study was selected based on a previous study regarding the analgesic effect of epidural dexamethasone in adults. 11 In the previous study, effective analgesia was provided by 5 mg of epidural dexamethasone but not 5 mg of i.v. dexamethasone in patients undergoing laparoscopic cholesystectomy, 11 which implied that epidural dexamethasone has greater analgesic efficacy than i.v. dexamethasone at the same dose. Although the dose of i.v. dexamethasone for analgesia is controversial, 7 8 a meta-analysis demonstrated that more than 0.1 mg kg 21 of i.v. dexamethasone is needed for postoperative analgesia. 7 Therefore, we did not consider administration of i.v.
dexamethasone in a control group. In a paediatric population, another meta-analysis that focused on the effects of systemic dexamethasone on nausea, vomiting, and pain after tonsillectomy demonstrated that the dose of i.v. dexamethasone leading to pain reduction was 0. dexamethasone does not seem to provide clinically relevant analgesia in children. Although the effect of caudal dexamethasone through systemic absorption on analgesia cannot be excluded in this design, our study clearly demonstrates that caudal dexamethasone can provide clinically relevant analgesia even at a low dose in children undergoing orchiopexy. Secondly, the mean age of our population was 14 months. Thus, the infants and children in this study might not be able to express their pain fully to parents. We assessed pain using NRS scores evaluated by parents. Presumably, parental perception of paediatric pain was based on an interpretation of their child's behavioural expression of pain. Hence, this method may not have been as accurate as self-reported pain scores. 39 Despite these limitations, NRS scores by parents in paediatric patients have been validated and correlated well with medical observers. 15 Thirdly, we did not evaluate some potential adverse effects of dexamethasone such as hyperglycaemia and adrenal suppression. Because the children in day-case orchiopexy did not require postoperative laboratory testing, we did not want to introduce invasive techniques for further blood sampling. However, previous studies have demonstrated that a single small dose of dexamethasone is not associated with significant side-effects. 26 In conclusion, the addition of 0.1 mg kg 21 dexamethasone to ropivacaine for caudal blocks could significantly improve analgesic efficacy in children undergoing orchiopexy.
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